German pharma company Fresenius Kabi has launched its severe hypothyroidism treatment -Levothyroxine Sodium Injection Solution in 100 mcg per 5 mL, 200 mcg per 5 mL and 500 mcg per 5 mL single-dose vials in the US. The Levothyroxine Sodium Injection is the first-and-only approved solution formulation by the FDA for this medicine available in […]
Fresenius Kabi, the global German healthcare company, has unveiled Methocarbamol Injection, USP in the United States, marking a significant expansion of its anesthesia and analgesia portfolio. The 100 mg per mL, 10 mL vial presentation is designed to assist in relieving the discomfort associated with acute, painful musculoskeletal conditions. This new injectable treatment, which can […]
German health care company Fresenius Kabi has announced the US launch of its new generic drug, Arsenic Trioxide Injection. This product, a generic version of Teva Pharmaceutical Industries’ leukemia treatment Trisenox, is set to offer a more affordable option for patients battling acute promyelocytic leukemia (APL). Arsenic Trioxide Injection for Acute Promyelocytic Leukemia Arsenic Trioxide […]